AzTrials
AzTrials

Performance PredictionNCT07564388

Cochlear-Implant-Performance-Prediction

A study testing cochlear implant user performance prediction in people with Performance Prediction, run by Northwestern University at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Despite improved technology, many cochlear implant (CI) recipients still struggle to understand speech in noise (SIN). Because the bottom-up acoustic signal generated by the implant is distorted relative to normal-hearing acoustic input, CI users rely more on top-down processing to decipher masked speech. Read more about this study

Who is it for?
Ages Up to 18 yearsHealthy volunteers can take part
Conditions the study is for
Performance Prediction
What is being tested?
cochlear implant user performance prediction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
25 Jun 2025to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • All participants who do not fit the exclusion criteria.

Who cannot join

  • Individuals who are not yet adults (infants, children, teenage children),
  • Adults unable to consent,
  • Adults with known impaired decision-making capacity,
  • Pregnant women,
  • Prisoners (or other detained/paroled individuals),
  • Students or postdoctoral trainees who are taught by or academically mentored by the Principal Investigator, in compliance with the Enrollment of Students and Trainees in Research Studies policies.
Show all 9Show fewer
  • Non-fluent English speakers, Tests (specifically Scrambled Letters and QuickSIN) require proficiency in the English language.
  • Individuals with severe hearing impairment, Tests (specifically QuickSIN) require participants to not have trouble hearing speech.
  • Individuals with significant, uncorrected visual impairment. All visual tests require the participant to be able to read medium-sized text on a screen approximately two feet in front of them.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Northwestern Univeristy

    Chicago, Illinois, 60611

Other trials in United States

About this study

Despite improved technology, many cochlear implant (CI) recipients still struggle to understand speech in noise (SIN). Because the bottom-up acoustic signal generated by the implant is distorted relative to normal-hearing acoustic input, CI users rely more on top-down processing to decipher masked speech. To better predict outcomes for CI recipients, top-down auditory processing ability should be assessed. However, hearing impairment makes testing top-down auditory processing ability through auditory means difficult. The study aims to determine whether testing visual top-down processing can predict auditory top-down processing capability.

Read the detailed description

Participants will complete a proctored, 25-minute computer-based test battery of visual cognitive tests (Stroop Test, Trail-Making Tests), visual distorted-signal tests (Scrambled Letters, VisualSNR), and auditory threshold tests (QuickSIN, Hearing Test). To prevent the accumulation of mental fatigue, tests will be administered in a predetermined order designed to minimize it. Including time for explanations for each test and questions from the participant about the testing protocol, the total time the participant will spend on the study is approximately 45 minutes.

Being tested
cochlear implant user performance prediction
Keywords
Cochlear implants, user performance prediction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cochlear implant user performance predictionDiagnostic test

    A battery of visual cognitive tests will be combined to identify a set of tests that can predict user performance in speech-in-noise and music perception.

Study groups in NCT07564388
Study groupRoleWhat they receive
performance assessmentExperimentalNot described
Receives: Diagnostic Test: cochlear implant user performance prediction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SNR-loss (dB)

    The Quick Sound-in-Noise (QuickSIN) test is a common method for assessing speech-in-noise perception. In this test, participants listen to sentences spoken by a female speaker in increasingly loud four-talker babble. The signal-to-noise ratio (SNR) loss for two QuickSIN tests will be averaged and recorded.

    Measured: baseline

  2. Audiogram

    Behavioral hearing threshold

    Measured: baseline

  3. Stroop times

    The Stroop Test assesses inhibition-concentration. This test consists of two sets of subtests. Each subtest requires reading 25 words from a table of colored words: the first subtest requires the participant to read the word, and the second requires the participant to name the color of the word. In the first set of subtests, the words will be colored corresponding to the meaning of the color word (i.e. 'Red' will be colored red). In the second set of subtests, the words will be colored in a different color than the meaning of the word (i.e.' Red' will be colored purple). The completion time of each subtest will be recorded.

    Measured: baseline

  4. Trail times

    The Trail-Making Test (TMT) assesses attention and processing speed. This test consists of subtests A and B. In part A, the participant must connect dots numbered 1-25 in numerical order. In part B, the participant must connect dots numbered 1-13 and dots labeled A-L in alternating order (i.e. 1-A-2-B). If the participant makes a mistake, they must correct the mistake before moving on. The completion time of each subtest will be recorded.

    Measured: baseline

  5. Percent identified

    The Scrambled Letters and VisualSNR tests were developed to assess the participant's ability to decipher garbled or distorted visual stimuli.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 May 2026
  2. Study start25 Jun 2025
  3. Primary completion1 Jun 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07564388
Sponsor's protocol ID
STU00223538
Status last verified
May 2026
First submitted
27 Apr 2026
Last updated
29 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing cochlear implant user performance prediction in people with Performance Prediction, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 29 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SNR-loss (dB) (time frame: baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in